Point72 Asset Management, L.P.

Position in MGNX — Macrogenics Inc

CIK 1603466 STAMFORD, CT

Position in MGNX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$602,804

+$201,662 QoQ

Shares Held

208,583

-16.3% QoQ

Ownership

0.328%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Mar 31, 2026

Point72 Asset Management, L.P. holds $2,393,450,612 across 188 Biotechnology names. MGNX ranks #139 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	APLS	Apellis Pharmaceuticals, Inc.	4,183,918	$168,319,021
2	MDGL	Madrigal Pharmaceuticals, Inc.	225,510	$118,047,719
3	CLDX	Celldex Therapeutics, Inc.	3,229,939	$102,453,665
4	RYTM	Rhythm Pharmaceuticals, Inc.	846,801	$73,646,282
5	AXSM	Axsome Therapeutics, Inc.	424,750	$71,791,245
6	ABVX	Abivax S.A.	637,736	$71,011,903
7	LEGN	Legend Biotech Corp	3,886,017	$70,298,047
8	JAZZ	Jazz Pharmaceuticals plc	358,634	$67,799,757

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$602,804	208,583	-16.3%	Shares	Defined	2026-05-15
2025-12-31	$401,142	249,157	+46040.2%	Shares	Defined	2026-02-17
2023-03-31	$3,871	540	-100.0%	Shares	Defined	2023-05-15
2021-12-31	$20,225,584	1,260,161	+42.6%	Shares	Defined	2022-02-14
2021-09-30	$18,499,673	883,461	+113.9%	Shares	Defined	2021-11-15
2021-06-30	$11,095,866	413,100	-28.5%	Shares	Defined	2021-08-16
2021-03-31	$18,399,745	577,700	-60.4%	Shares	Defined	2021-05-17
2020-12-31	$33,378,640	1,460,133	-59.4%	Shares	Defined	2021-02-16
2020-09-30	$90,560,040	3,595,079	+164.3%	Shares	Defined	2020-11-16
2020-06-30	$37,974,829	1,360,130	+668.2%	Shares	Defined	2020-08-14
2020-03-31	$1,030,506	177,063	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.